Orchid Pharma Schedules Board Meeting for Q2 and H1 Results
Orchid Pharma Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Orchid Pharma Schedules Board Meeting for Q2 and H1 Results Orchid Pharma Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Orchid Pharma Ltd
- Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited ('the Company') 路 18 Nov 2026
- Board Comments on fine levied by Stock Exchanges 路 17 Nov 2026
- Investor Presentation-Quarter II of FY 2026-27, ended on September 30, 2026 路 17 Nov 2026
- Statement of deviation or variation for the quarter ended on September 30, 2026 on the use of proceeds of funds raised through Qualified institutional placement (QIP) 路 14 Nov 2026
- Declaration of Financial results for quarter and half year ended on September 30, 2026 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Monitoring Agency Report for the Quarter-II ended on September 30, 2026 路 14 Nov 2026
